维普中文期刊产品整合服务
125篇 您的检索式:作者名="FAZIA M"
    题名 作者 年代 出处 被引量
1HOPS: a novel cAMP - dependent shuttling protein involved in protein synthesis regulation显示文摘Della Fazia MA Castelli M Bartoli D 2005J Cell Sci2005,118,14:1
2HOPS: a novel cAMP-dependent shuttling protein involved in protein synthesis regulation显示文摘Delia Fazia MA Castelli M Bartoli D 2005J Cell Sci2005,118,14:1
3Association between 5-lipoxygenase expression and plaque instability in humans 显示文摘CIPOLLONE F MEZZETTI A FAZIA M L 2005Arterioscler Thromb Vasc Biol2005,25,:1
4Increased expression of transforming growth factor - betal as a stabilizing factor in human atherosclerotic plaques 显示文摘Cipollone F Fazia M Mincione G 2004Stroke2004,35,10:1
5Elevated circulating of monocyte chemottractant protein-1 in patients with restenosis after coronary angioplasty 显示文摘CIPOLLONE F MARINI M FAZIA M 2001Artcrioscl Thromb Vasc Biol2001,21,3:1
6Suppression of the functionallycoupled cycloxygenase-2/pROStaglandin F,synthase as a basis of simvastatin dependent plaque stabilization in humans显示文摘Cipollone F Fazia M Lezzi A 2013Circulation2013,107,11:1
7The receptor RAGE as a progression factor amplifying arachidonate-dependent infiammatory and proteolytic response in human athemselerotie plaques:role of glycemic control显示文摘CIPOLLONE F IEZZI A FAZIA M 2003Circulation2003,108,9:1
8Blockade of the angiotensin Ⅱ type 1 receptor stabilizes atherosclerotic plaques in humans by inhibi- ting prostaglandin E-dependent matrix metalloproteinase activity显示文摘Cipollone F Fazia M Iezzi A 2004Circulation2004,30,12:1
9The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atheresclewtic plaques: role of glycemic tonal 显示文摘Cipollone F lezzi A Fazia M 2003Circulation2003,108,9:1
10The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in hman atherosclerotic plaques:Role of glycemic control显示文摘Cipollone F Iezzi A Fazia M 2003Circulation2003,108,9:1
11Suppression of the functionally coupled cyclooxygenase-2 / prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans显示文摘Cipollone F Fazia M Iezzi A 2003Circulation2003,107,11:1
12Blockade of the angiotensin Ⅱ type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependcnt matrix metalloproteinase activity 显示文摘Cipollone F Fazia M lezzi A 2004Circulation2004,109,12:1
13Novel determinants of plaque instability显示文摘 Fazia M Mezzetti A 2005J Thromb Haemost2005,3,:1
14Suppression of the functionally -coupled eyeloxygenase-2/pROStaglandinF, synthase as a basis of simvastatin dependent plaque stabilization in humans显示文摘Cipollone F Fazia M Lezzi A 2013Cireulation2013,107,11:1
15Suppression of the functionally coupled cyclooxygenase -2/prostaglandin E synthase as a basis of simvastatin dependent plaque stabilization in humans显示文摘Cipollone F Fazia M lezzi A 2003Circulation2003,107,3:1
16Increased expression of trans- forming growth factor - 1 as a stabilizing factor in human athemselerot- ic plaques显示文摘Cipollonc F Fazia M Mincione G 2004Stroke2004,35,:1
17The receptor RAGE as a progression factor amplifying araehidonate dependent inflammatory and proteolytic response in human atherosclerotic plaques:role of glycemic control显示文摘Cipollone F Iezzia Fazia M 0,,09:1
18Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans显示文摘Cipollone F Fazia M Iezzi A 2003Circulation2003,107,11:1
19Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans显示文摘Cipollone F Fazia M lezzi A 2003Circulation2003,107,11:1
20Balance between PGD Synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans显示文摘Cipollone F Fazia M Lezzi A 2004Arterioscl Throm Vasc Biol2004,24,7:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费